Pharming Group NV (OTCMKTS:PHGUF – Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 264,000 shares traded hands during trading, an increase of 3,499% from the previous session’s volume of 7,336 shares.The stock last traded at $1.20 and had previously closed at $1.28.
Pharming Group Price Performance
The stock’s 50-day moving average price is $1.46 and its two-hundred day moving average price is $1.61. The stock has a market capitalization of $771.73 million, a PE ratio of 57.53 and a beta of 0.45. The company has a debt-to-equity ratio of 0.40, a quick ratio of 2.06 and a current ratio of 2.63.
Pharming Group (OTCMKTS:PHGUF – Get Free Report) last released its earnings results on Thursday, May 7th. The biotechnology company reported ($0.01) earnings per share for the quarter. The business had revenue of $72.45 million during the quarter, compared to analysts’ expectations of $92.06 million. Pharming Group had a return on equity of 4.64% and a net margin of 3.30%.
Pharming Group Company Profile
Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.
Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.
See Also
- Five stocks we like better than Pharming Group
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
